Hi,亲爱的朋友们~让我们一起来解密创新药板块中报预告。随着2025中报业绩预告陆续披露,创新药板块继续成为市场关注的焦点。在医保目录改革提速、国际化授权(License-out)加速的背景下,中国创新药行业分化明显,头部企业业绩亮眼,部分企业面临亏损。谁在创新药突围而出?盘点中报预告,业绩最亮眼的翰宇药业,从连年亏损到强势翻盘,上半年净利润同比增长超16倍,成功扭转连续多年扣非净利润亏损的局面,...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.